Cecilia Querebalu Garcia

Cecilia Querebalu Garcia

Auto-generated profile, based on publicly available information

Cecilia Querebalu Garcia

Facultad de Ciencias Físicas

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2026 in Radiation Protection Dosimetry
Verified
Journal Article
Closed access
PPPaul Elias Panizo-Olivos
Paul Elias Panizo-Olivos
CQCecilia Querebalú-García
Cecilia Querebalú-García
EGEduardo Garnique-Millones
Eduardo Garnique-Millones
ADAdlin López Díaz
Adlin López Díaz
JBJhonny Antonio Benavente-Castillo
Jhonny Antonio Benavente-Castillo
JDJorge Lázaro Delgado-Morales
Jorge Lázaro Delgado-Morales
Diagnostic reference levels (DRLs) are tools for optimizing medical exposures. We performed a retrospective analysis of 898 adult scintigraphic examinations acquired between 2018 and 2024 at a Peruvian hospital to establish institutional DRLs for eight procedures. Typical values were defined as the median administered activity, and the 75th percentiles were used as institutional action levels to trigger protocol review. Median weight-normalized activities ranged from 0.1 MBq·kg−1 for 131I thyroid uptake testing to 14.5 MBq·kg−1 for three-phase bone scintigraphy; corresponding derived effective dose estimates were ~1–45 mSv and are reported only for population-level benchmarking. Comparison with international DRLs showed broad concordance; however, bone scintigraphy exceeded several reference values by >25%, indicating opportunities for optimization. These results provide the first institutional DRLs reported in Peru, identify priorities for local quality improvement, and support periodic review within an optimization cycle.

1 July 2026 in Revista Mexicana de Física
Verified
Journal Article
Open access
PDF file
CGCecilia Querebalu Garcia
Cecilia Querebalu Garcia
POPaul Elias Panizo Olivos
Paul Elias Panizo Olivos
EMEduardo Garnique Millones
Eduardo Garnique Millones
CMChristian Heyrner Barragan Mondragon
Christian Heyrner Barragan Mondragon
JPJosé Fernando Márquez Pachas
José Fernando Márquez Pachas
ESEduardo Becquer Carrasco Solis
Eduardo Becquer Carrasco Solis
Radiation exposure in mammography can vary considerably across centers, potentially affecting both diagnostic quality and patient safety. In Trujillo, Peru, no locally adjusted absorbed dose values were previously available. Therefore, the objective of this study was to establish local diagnostic reference levels (LDRLs) for digital mammography within the EsSalud hospital network (Social Health Insurance) in Trujillo. A retrospective, multicenter study was conducted in three hospitals, analyzing 133 digital mammograms acquired with Hologic Selenia Dimensions systems. Technical parameters such as kilovoltage, tube load, compression force, compressed breast thickness, and average glandular dose (AGD) were collected and processed using automated systems. The LDRLs, defined as the 75th percentile of the AGD distribution, were determined for the craniocaudal (CC) and mediolateral oblique (MLO) projections. Multiple linear regression analysis was performed to identify independent predictors of AGD. The proposed LDRLs were 1.78 mGy for CC and 2.12 mGy for MLO, values well below the reference level of 3 mGy recommended by the Basic Safety Standards of the International Atomic Energy Agency (IAEA), and 30 − 39% lower than the regional LDRLs previously reported for direct digital radiography (DDR) systems in Latin America. Tube load (β = 0.886, p < 0.001 for CC; β = 0.572, p < 0.001 for MLO) and compressed breast thickness (β = 0.193, p < 0.001 for CC; β = 0.297, p = 0.001 for MLO) were identified as the most significant technical predictors of AGD. The established LDRLs demonstrate optimized dosimetric practices within the EsSalud network in Trujillo, ensuring that patient doses are appropriate, consistent, and aligned with international standards. Their implementation will facilitate ongoing dose monitoring, protocol standardization, and the strengthening of radiation protection in breast cancer screening programs.